Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yonezawa Hamari Chemicals is a Japanese contract development and manufacturing organization (CDMO) specializing in the production of active pharmaceutical ingredients (APIs) and intermediates. As a key manufacturing subsidiary of Hamari Chemicals, the company operates advanced facilities in Yonezawa, Yamagata Prefecture, which are compliant with global GMP standards including US FDA and PMDA regulations. Their technical expertise spans complex small molecule synthesis, high-potency APIs (HPAPIs), and peptide manufacturing. In addition to pharmaceutical components, they produce high-quality ingredients for the food and cosmetic industries. The company provides comprehensive services from process development and scale-up to commercial-scale production for global pharmaceutical partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yonezawa Hamari Chemicals.